BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7890777)

  • 1. Mapping of the interaction site of the defective transcription factor in the class II major histocompatibility complex mutant cell line clone-13 to the divergent X2-box.
    Ono SJ; Song Z
    J Biol Chem; 1995 Mar; 270(11):6396-402. PubMed ID: 7890777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An isotype-specific trans-acting factor is defective in a mutant B cell line that expresses HLA-DQ, but not -DR or -DP.
    Ono SJ; Bazil V; Sugawara M; Strominger JL
    J Exp Med; 1991 Mar; 173(3):629-37. PubMed ID: 1997650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two B cell factors bind the HLA-DRA X box region and recognize different subsets of HLA class II promoters.
    Hasegawa SL; Boss JM
    Nucleic Acids Res; 1991 Nov; 19(22):6269-76. PubMed ID: 1956787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma.
    Wright KL; Ting JP
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7601-5. PubMed ID: 1502171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the X2 box in activated transcription from the DRA promoter in B cells.
    Setterblad N; Peterlin BM; Andersson G
    Immunogenetics; 1997; 46(4):318-25. PubMed ID: 9218534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conserved residues of the bare lymphocyte syndrome transcription factor RFXAP determine coordinate MHC class II expression.
    Long AB; Ferguson AM; Majumder P; Nagarajan UM; Boss JM
    Mol Immunol; 2006 Feb; 43(5):395-409. PubMed ID: 16337482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of differential HLA-DQB expression in autologous B cell lines.
    Woolfrey AE; Andersen LC; Shewey L; Chung J; Nepom GT
    J Leukoc Biol; 1993 Jun; 53(6):697-706. PubMed ID: 8315353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The X1 box of HLA-G promoter is a target site for RFX and Sp1 factors.
    Rousseau P; Paul P; O'Brien M; Dausset J; Carosella ED; Moreau P
    Hum Immunol; 2000 Nov; 61(11):1132-7. PubMed ID: 11137218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class II MHC transcriptional mutants are defective in higher order complex formation.
    Riley JL; Boss JM
    J Immunol; 1993 Dec; 151(12):6942-53. PubMed ID: 8258702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An isotype-specific activator of major histocompatibility complex (MHC) class II genes that is independent of class II transactivator.
    Douhan J; Lieberson R; Knoll JH; Zhou H; Glimcher LH
    J Exp Med; 1997 Jun; 185(11):1885-95. PubMed ID: 9166418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human X-box-binding protein 1 is required for the transcription of a subset of human class II major histocompatibility genes and forms a heterodimer with c-fos.
    Ono SJ; Liou HC; Davidon R; Strominger JL; Glimcher LH
    Proc Natl Acad Sci U S A; 1991 May; 88(10):4309-12. PubMed ID: 1903538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of cis-linked regulatory sequences in the HLA DRA promoter by transcription in vitro.
    Hume CR; Lee JS
    Tissue Antigens; 1990 Sep; 36(3):108-15. PubMed ID: 2278044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional roles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expression.
    Abdulkadir SA; Krishna S; Thanos D; Maniatis T; Strominger JL; Ono SJ
    J Exp Med; 1995 Aug; 182(2):487-500. PubMed ID: 7629508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single base pair substitutions within the HLA-DRA gene promoter separate the functions of the X1 and X2 boxes.
    Sloan JH; Hasegawa SL; Boss JM
    J Immunol; 1992 Apr; 148(8):2591-9. PubMed ID: 1560213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DRA promoter polymorphism and diversity generation within the immune system.
    Schwiebert LM; Hughes A; Monos DS; Ono SJ
    Hum Genet; 1997 Jun; 99(6):801-5. PubMed ID: 9187677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allelic polymorphism in transcriptional regulatory regions of HLA-DQB genes.
    Andersen LC; Beaty JS; Nettles JW; Seyfried CE; Nepom GT; Nepoom BS
    J Exp Med; 1991 Jan; 173(1):181-92. PubMed ID: 1985121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-box-binding proteins positively and negatively regulate transcription of the HLA-DRA gene through interaction with discrete upstream W and V elements.
    Cogswell JP; Basta PV; Ting JP
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7703-7. PubMed ID: 2120707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha response elements in the HLA-DRA promoter: identification of a tumor necrosis factor alpha-induced DNA-protein complex in astrocytes.
    Panek RB; Moses H; Ting JP; Benveniste EN
    Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11518-22. PubMed ID: 1454841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The function of the octamer-binding site in the DRA promoter.
    Voliva CF; Jabrane-Ferrat N; Peterlin BM
    Immunogenetics; 1996; 43(1-2):20-6. PubMed ID: 8537118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sequencing and genetic analysis of a bovine DQB cDNA clone.
    Xu A; Clark TJ; Teutsch MR; Schook LB; Lewin HA
    Anim Genet; 1991; 22(5):381-98. PubMed ID: 1776708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.